Built for the realities of MLR


How AI-powered ERMA Evaluate helps life sciences teams move faster with flexibility, efficiency and intelligent compliance.

Life sciences organizations operate in one of the world’s most highly regulated marketing environments.

Every promotional asset — from digital campaigns to congress materials and sales tools — must pass through Medical-Legal-Regulatory (MLR) review before reaching healthcare professionals or patients. The process exists for an important reason: to ensure that communications remain scientifically accurate, balanced and aligned with regulatory guidance.

Yet while regulatory expectations remain constant, the pace of life sciences marketing has changed dramatically.

Brand teams now launch omnichannel campaigns simultaneously across digital channels, field teams and medical education programs. Messaging evolves quickly as new clinical data emerges and market dynamics shift. As a result, organizations need compliance infrastructure that can keep pace with both regulatory expectations and operational demands.

ERMA Evaluate was designed to meet that challenge.

By combining purpose-built AI with flexible workflow architecture, ERMA helps life sciences organizations modernize promotional review while maintaining the rigor required for regulatory compliance.

Building the platform the right way

Many compliance platforms attempt to apply technology to already complex workflows.

However, promotional review is more than a document-routing exercise. It requires careful coordination between medical, legal, regulatory and commercial stakeholders — all working to ensure that scientific messaging is accurate, balanced and supported by evidence.

ERMA Evaluate was designed with these challenges in mind.

From the earliest stages of development, the platform was shaped with input from experienced industry leaders who understand the operational realities of MLR review. Their guidance provided real-world examples of how teams manage claims, references, approvals and documentation throughout the review process.

This insight helped ensure that ERMA Evaluate was not designed around theoretical workflows, but around the way promotional review actually happens inside life sciences organizations.

The result is a platform designed around industry needs — rather than forcing teams to adapt to rigid technology.

AI designed specifically for MLR review

Artificial intelligence is transforming many aspects of life sciences operations. In promotional review, AI has the potential to reduce the administrative burden that often slows MLR processes.

ERMA Evaluate integrates AI directly into the review workflow to support several critical functions.

The platform automatically identifies claims within promotional materials, helping reviewers quickly locate statements that require scientific validation. Unlike traditional systems, ERMA Evaluate does not rely on a claims database that must be constantly maintained or purged. Instead, it dynamically detects claims within the content itself and supports reference management by linking those claims directly to appropriate supporting evidence, maintaining full traceability throughout the review process.

By helping teams identify and organize key compliance elements earlier in the workflow, AI allows reviewers to focus more on evaluating the scientific and regulatory integrity of the content itself.

Rather than replacing human expertise, ERMA Evaluates AI capabilities are designed to support it — helping teams enter the review process with materials that are cleaner, more organized and better prepared for evaluation.

Flexibility for a changing industry

No two life sciences organization’s structure MLR review in exactly the same way.

Some companies operate centralized review committees, while others rely on distributed teams across therapeutic areas or geographic regions. Workflows often evolve as organizations grow, launch new products or enter new markets.

ERMA Evaluate was designed with this variability in mind.

The platform provides flexible, configurable workflows that allow organizations to align the system with their internal governance structures. Review routing, approval checkpoints and collaboration processes can be configured to support the way each organization operates.

This flexibility helps companies maintain consistent compliance practices while adapting their processes as business needs evolve.

Built for organizations that need to pivot

The life sciences landscape continues to change rapidly.

New clinical data can shift how products are positioned. Competitive pressures may require updates to promotional messaging. Digital engagement strategies continue to expand across new channels and formats.

Organizations need systems that can evolve alongside these changes.

ERMA’s evaluates adaptable architecture allows teams to adjust workflows, collaborate across stakeholders and maintain visibility across promotional materials as they move through review.

For emerging biotech companies and mid-sized pharmaceutical organizations in particular, this ability to pivot quickly can be essential to maintaining both compliance and commercial momentum.

Driving operational efficiency

Beyond flexibility, many organizations are also seeking ways to reduce the operational burden associated with promotional review.

Managing documents, references, approvals and regulatory documentation across multiple systems can introduce inefficiencies and increase administrative workload.

ERMA Evaluate addresses these challenges by bringing key capabilities into a single platform.

AI-powered claim identification, reference management tools and document lifecycle tracking help streamline the review process while maintaining the documentation required for compliance.

The platform also supports multi-tenant collaboration, enabling internal teams, agencies and external partners to work within the same environment.

By reducing manual tasks and improving coordination across stakeholders, ERMA can help organizations reduce review cycles and improve operational efficiency.

Supporting the full promotional review lifecycle

ERMA Evaluate supports life sciences teams throughout the full promotional review lifecycle.

Key capabilities include:

  • AI-powered claim identification that detects promotional and scientific claims within marketing materials
  • Reference management that links claims to supporting evidence and maintains traceability
  • Flexible configurable workflows aligned with organizational governance structures
  • Multi-tenant collaboration across internal teams, agencies and external partners
  • Document lifecycle management from creation through approval, expiration and re-approval
  • Preparation support for eCTD and FDA Form 2253 regulatory submissions

Together, these capabilities help promotional materials move through review more efficiently while maintaining the documentation required for regulatory compliance.

Technology built for the future of MLR

The demands placed on life sciences organizations will continue to evolve as marketing channels expand and regulatory expectations develop.

Compliance infrastructure must evolve alongside these changes.

By combining AI-driven intelligence, flexible workflow architecture and collaborative environments, ERMA Evaluate was designed to support the future of promotional review.

For organizations seeking a modern approach to compliance — one that balances rigor with efficiency — technology built around the realities of the industry may provide an effective path forward.

Start your free trial for ERMA Evaluate at www.ermasystems.com/trial